OpenSAFELY Vaccine Coverage Report

First dose / Priority Group 5

Data from combined, up to 2021-03-20.

Vaccinated at 2021-03-20 (%) Vaccinated at 2021-03-20 (n) Population Vaccinated at 2021-03-13 (%) Vaccinated in past week (%)
Overall - 89.7% 2,217,460 2,473,177 88.6% 1.1%
Sex Female 90.4% 1,140,174 1,261,750 89.4% 1.0%
Male 88.9% 1,077,286 1,211,427 87.8% 1.1%
Ethnicity White - British 93.6% 1,355,466 1,448,426 92.6% 1.0%
White - Irish 87.4% 13,657 15,617 86.5% 1.0%
White - Any other White background 66.9% 52,990 79,205 65.8% 1.1%
Mixed - White and Black Caribbean 66.7% 2,114 3,171 64.7% 2.0%
Mixed - White and Black African 66.5% 1,708 2,569 65.1% 1.4%
Mixed - White and Asian 83.3% 2,128 2,555 82.2% 1.1%
Mixed - Any other mixed background 75.5% 3,731 4,942 73.9% 1.6%
Asian or Asian British - Indian 87.4% 43,967 50,323 86.5% 0.8%
Asian or Asian British - Pakistani 72.2% 18,032 24,983 70.4% 1.8%
Asian or Asian British - Bangladeshi 83.4% 5,159 6,188 81.3% 2.0%
Asian or Asian British - Any other Asian background 81.6% 18,291 22,428 80.3% 1.2%
Black or Black British - Caribbean 58.8% 8,792 14,959 56.6% 2.2%
Black or Black British - African 62.2% 9,492 15,260 60.0% 2.2%
Black or Black British - Any other Black background 64.6% 2,352 3,640 63.1% 1.5%
Other ethnic groups - Chinese 71.6% 6,741 9,415 70.3% 1.3%
Other ethnic groups - Any other ethnic group 68.4% 9,072 13,265 67.1% 1.3%
Patients with any other ethnicity code 90.7% 296,415 326,963 89.6% 1.1%
Ethnicity not stated 84.5% 12,733 15,071 83.3% 1.2%
Ethnicity not recorded 85.6% 354,529 414,092 84.5% 1.2%
Ethnicity (broad categories) White 92.2% 1,422,127 1,543,255 91.2% 1.0%
Mixed 73.2% 9,702 13,258 71.6% 1.5%
South Asian 82.2% 85,456 103,936 81.0% 1.2%
Black 61.0% 20,650 33,873 58.9% 2.1%
Other 69.7% 15,813 22,680 68.4% 1.3%
Unknown 87.8% 663,691 756,140 86.7% 1.1%
Index of Multiple Deprivation 1 (most deprived) 83.2% 306,782 368,557 81.5% 1.7%
2 86.8% 384,167 442,575 85.5% 1.3%
3 90.2% 473,585 524,776 89.2% 1.0%
4 92.0% 507,703 551,684 91.2% 0.9%
5 (least deprived) 93.2% 525,924 564,004 92.5% 0.7%
Unknown 89.4% 19,278 21,560 88.6% 0.8%
Clinical Risk Groups Patients in Any Clinical Risk Group 91.5% 828,590 905,772 90.4% 1.1%
Patients with Immunosuppression 93.2% 35,189 37,744 92.3% 0.9%
Patients with CKD 92.5% 108,213 116,942 91.5% 1.0%
Patients who have Chronic Respiratory Disease 91.4% 88,354 96,677 90.3% 1.1%
Patients with Diabetes 91.1% 296,534 325,444 90.0% 1.1%
Patients with Chronic Liver disease 90.8% 66,836 73,640 89.6% 1.1%
Patients with CNS Disease (including Stroke/TIA) 91.5% 123,655 135,184 90.3% 1.2%
Patients with Chronic heart disease 92.3% 346,528 375,557 91.2% 1.1%
Patients with Asplenia or Dysfunction of the Spleen 93.9% 13,307 14,168 93.1% 0.8%
Patients with Wider Learning Disability 85.8% 4,984 5,810 82.4% 3.4%
Patients with Severe Mental Health 80.6% 19,131 23,737 78.5% 2.1%
Other Groups Patients with Morbid Obesity 91.1% 71,092 78,064 89.7% 1.3%
Patients who are pregnant 91.7% 231 252 91.7% 0.0%